Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GNC Targets ‘Consumer Trust’ In N.Y. Agreement, But Industry Wary Of Impact

This article was originally published in The Pink Sheet Daily

Executive Summary

As GNC explains why it accepted an agreement with N.Y. to resolve accusations about adulterated herbal supplements, industry stakeholders at Ingredient Marketplace discuss strategies on refuting those allegations and informing consumers about the quality control that is a hallmark for much of the industry.

You may also be interested in...



Making Nutritionals Eligible For Health Savings Accounts Whets Congress' Appetite

The supplement Industry and members of Congress open a line of communication on including dietary supplements into FSA/HSA spending programs, says CRN President Steve Mister.

J&J Settlement With States Not Likely To Be Precedent In OTC Space

J&J's agreement with 42 states and Washington, D.C. is its latest cost from widespread GMP problems that prompted recalls and led to a 2011 FDA consent decree. But the unusual combination of factors suggest more such state actions are unlikely to follow.

J&J Settlement With States Not Likely To Be Precedent In OTC Space

J&J's agreement with 42 states and Washington, D.C. is its latest cost from widespread GMP problems that prompted recalls and led to a 2011 FDA consent decree. But the unusual combination of factors suggest more such state actions are unlikely to follow.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel